flurbiprofen has been researched along with Day Blindness in 2 studies
Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
McDonald, MB | 1 |
Wyse, TB | 1 |
Borodkin, MJ | 1 |
Ocmand, A | 1 |
Shoelson, B | 1 |
Thompson, H | 1 |
Zollman, TM | 1 |
Bragg, RM | 1 |
Harrison, DA | 1 |
2 trials available for flurbiprofen and Day Blindness
Article | Year |
---|---|
Comparison of the effectiveness of 4 anti-inflammatory drops in relieving photophobia after pupil dilation.
Topics: Adolescent; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Bl | 1999 |
Clinical effects of oleoresin capsicum (pepper spray) on the human cornea and conjunctiva.
Topics: Adult; Analgesics; Anesthetics, Local; Conjunctiva; Cornea; Female; Flurbiprofen; Humans; Male; Midd | 2000 |